Bladder cancer
Conditions
Interventions
test group:BL-5ALA-PDT
Control group:None
Sponsors
the First Affiliated Hospital of Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Pathological result was identified as high-risk NMIBC, satisfy any of the following terms: (1) T1 tumor; (2) G3 or high-grade urothelial cancer; (3) CIS; (4) multiple, recurrent and TaG1-2 or low diameter > 3cm); 2. EORTC score above 5; 3. Patients aged 18-80 years, agreed (or authorized) to participate in the clinical trial and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Serious systemic diseases (such as severe coagulation dysfunction, decompensation of important organ function) or chronic wasting diseases; 2. Patients have a history of other malignant tumors in the past five years; 3. Pregnant and lactating women; 4. Those who have received large surgery within 1 month before the selection; 5. Participants in other clinical trials; 6. Other conditions (such as mental disorders).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor recurrence rate at 1 year after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| complication; | — |
Countries
China
Contacts
Public ContactHe Dalin
the First Affiliated Hospital of Xi'an Jiaotong University
Outcome results
None listed